Diagnosis of Tuberculosis in Swiss Children
Recruiting now
Conditions studied: Tuberculosis, Mycobacterium Tuberculosis
In brief
1. The primary objective is to improve the sensitivity of novel immunodiagnostic tests for detection of TB disease in children. 2. The secondary objective is to determine biomarkers that discriminate children with TB infection and disease.
Key facts
- Study ID
- NCT03044509
- Run by
- University Children's Hospital Basel
- People needed
- 190
- Starts
- 2017-05-12
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2024-09-19
Who can join
Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- all children / adolescents < 18 years of age undergoing evaluation for TB exposure, infection or disease.
You may not qualify if…
- children / adolescents with TB infection or disease who have already been started on anti-mycobacterial treatment, children who have been treated for TB previously.
Where it is running
- Kantonspital Aarau — Aarau, Switzerland (enrolling)
- Nina Vaezipour — Basel, Switzerland (enrolling)
- Ospedale Regionale di Bellinzona — Bellinzona, Switzerland (enrolling)
- Inselspital Bern — Bern, Switzerland (enrolling)
- Hôpital des enfants - HUG — Geneva, Switzerland (enrolling)
- Kinserspital Luzern — Lucerne, Switzerland (enrolling)
- Kinderspital St Gallen — Sankt Gallen, Switzerland (enrolling)
- Kinderklinik Zürich — Zurich, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.